SEI Investments’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

SEI Investments’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-44,600	Closed	-$515K	–	2550
2020 Q3	$515K	Buy	+44,600	New	+$736K	﹤0.01%	1881
2019 Q4	–	Sell	-12,311	Closed	-$280K	–	2458
2019 Q3	$280K	Buy	+12,311	New	+$388K	﹤0.01%	2143

Other funds holding GTHX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SEI Investments's GTHX Position: Q4 2020 in Review

SEI Investments sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2020, closing a stake of 44,600 shares — an estimated $515K sold.

SEI Investments first reported a position in GTHX in Q3 2019 and held it in 2 quarters. The position peaked at $515K in Q3 2020. 125 funds tracked by Wall St. Rank hold GTHX as of Q4 2020.

SEI Investments reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
SEI Investments sold 44,600 G1 Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $515K.
SEI Investments first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
SEI Investments's G1 Therapeutics, Inc. Common Stock position peaked at $515K in Q3 2020.
125 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.